\n
![\"Take](\"https:\/\/www.securemac.com\/wp-content\/uploads\/2025\/05\/post-img-2-2.jpg\")
\t\t<\/span><\/p>\nCongress Passes Controversial \u201cTake It Down Act\u201d Amid Free Speech Concerns<\/h2>\n
\u00a0In a rare bipartisan move, Congress has passed and the White House has signed into law the Take It Down Act, a sweeping new regulation that targets nonconsensual intimate imagery, including revenge porn and AI-generated deepfakes. While hailed as a step forward for digital privacy rights, critics warn it may come with severe unintended consequences for online speech.<\/p>\n
Aimed at Protecting Privacy, Modeled on the DMCA<\/h3>\n
The law, set to take effect within a year, compels online platforms to remove intimate visual content posted without consent within 48 hours of a takedown request. Noncompliance could result in $50,000 fines per violation, according to Wired<\/a><\/em>.<\/p>\n The Take It Down Act is modeled after the Digital Millennium Copyright Act (DMCA), which has long allowed for swift takedown of infringing content. However, the DMCA has also been frequently abused by bad actors seeking to silence critics or harm competitors under false pretenses. The concern, free speech advocates say, is that this new law lacks even the minimal safeguards that exist under the DMCA.<\/p>\n \u201cFraudsters have abused the DMCA takedown process to get content censored for reasons that have nothing to do with copyright infringements,\u201d<\/em> Wired<\/em> reports.<\/p>\n One of the most glaring issues with the Take It Down Act, experts say, is the absence of penalties for bad-faith requests. Unlike the DMCA, which contains consequences for fraudulent claims, this new law only requires that takedown requestors act in \u201cgood faith,\u201d<\/em> with no meaningful deterrents or verification requirements.<\/p>\n Even more troubling to critics: there is no formal appeals process for content creators or alleged perpetrators to contest erroneous removals. Nor does the law carve out exemptions for content deemed in the public interest, further fueling concerns of overreach.<\/p>\n The 48-hour window for takedown places immense pressure on tech companies, many of which are already overwhelmed by volume and short on verification capacity. Google, for example, processes millions of DMCA takedown requests annually and has admitted in court that it \u201coften must rely\u201d<\/em> on the statements of claimants due to time constraints.<\/p>\n Free speech groups warn that the new law may lead to preemptive censorship, as companies err on the side of caution to avoid liability. This \u201cbetter safe than sorry\u201d<\/em> mindset could result in the unjust removal of legitimate cbontent, repeating the same cycle of DMCA abuse but with higher stakes and less recourse.<\/p>\n Proponents of the law emphasize its urgency and necessity, particularly in protecting victims\u2014many of them minors\u2014whose trauma was a catalyst for legislative action. The hope, lawmakers say, is that it will enable victims to reclaim privacy swiftly and decisively.<\/p>\n Yet, the Wired<\/a><\/em> report and critics alike suggest that in its current form, the Take It Down Act is a powerful but blunt instrument, one that risks being misused in ways that undermine digital expression and due process.<\/p>\n As one commentator put it, \u201cIt\u2019s hard to blame free speech people for being worried about leaving keys in the ignition of a bulldozer.\u201d<\/em><\/p>\n \u00a0Biotech giant Regeneron has emerged as the winning bidder in the bankruptcy auction of troubled genetic testing firm 23andMe<\/a>, setting the stage for a $256 million acquisition expected to finalize in Q3 of 2025. The deal comes in the wake of a massive data breach, plummeting user trust, and a slew of lawsuits that forced the once-celebrated DNA analysis company to file for bankruptcy in March.<\/p>\n According to a ZDNet report<\/a>, 23andMe\u2019s troubles began with a late-2023 breach that affected around 14,000 user accounts through a method known as credenbtial stuffing\u2014but the fallout reached much further. The attackers gained access to the DNA Relative profiles of 5.5 million users<\/strong>, exposing deeply personal information including:<\/p>\n Though the company initially blamed customers for reusing passwords, the breach reportedly impacted even those with unique credentials and two-factor authentication, thanks to how relational data was structured.<\/p>\n The breach triggered multiple class action lawsuits, which proved successful. Affected customers can now file claims for a share of a $30 million settlement\u2014a payout some have criticized as meager given the sensitivity and scope of the exposed data.<\/p>\n The financial and reputational damage from the lawsuits, combined with declining sales, led to 23andMe\u2019s bankruptcy filing in March 2025. The situation raised enough concern that the California Attorney General urged customers to delete their genetic data, warning of the unknown implications of an impending acquisition.<\/p>\n Founded in 1988 and based in Tarrytown, NY, Regeneron is a pharmaceutical heavyweight known for developing drugs in areas such as ophthalmology, immunology, and infectious diseases. In its statement following the auction, Regeneron emphasized its intent to respect 23andMe\u2019s consumer privacy policies and adhere to applicable laws. Notably, the company pledged transparency and oversight:<\/p>\n \u201c[We] are prepared to detail the intended use of customer data and the privacy programs and security controls in place for review by a court-appointed, independent Customer Privacy Ombudsman and other interested parties.\u201d \u2013 Regeneron press release<\/em><\/p>\n<\/blockquote>\n A company executive also touted Regeneron\u2019s experience with large-scale, deidentified genomic data, emphasizing the potential for medical breakthroughs while asserting a commitment to user privacy.<\/p>\n Despite the promises, skepticism remains high. Critics point out that 23andMe itself once pledged to safeguard its users\u2019 data\u2014until it didn\u2019t. The company will remain operational under Regeneron\u2019s ownership, now with mandatory two-factor authentication, though password hygiene remains a user responsibility.<\/p>\nMissing Guardrails and the Risk of Abuse<\/h3>\n
The Clock is Ticking \u2014 Literally<\/h3>\n
A Well-Intentioned Law With Real Risks<\/h3>\n
Regeneron Buys 23andMe After Data Breach Fallout: What It Means for Your DNA<\/h2>\n
The Breach That Broke 23andMe<\/h3>\n
\n
The Lawsuits and the $30 Million Settlement<\/h3>\n
Regeneron Steps In<\/h3>\n
\n
A Second Chance or More of the Same?<\/h3>\n